Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
The EMBO Journal
|
October 30, 2025
DNGR-1 signalling limits dendritic cell activation for optimal antigen cross-presentation
Michael D Buck, Tomás Castro-Dopico, Oliver Schulz, et al.
Frontiers in Immunology
|
December 17, 2020
Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19
Karel F A Van Damme, Simon Tavernier, Nele Van Roy, et al.
Immunity
|
May 12, 2020
Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection
Cedric Bosteels, Katrijn Neyt, Manon Vanheerswynghels, et al.
Cancer Research
|
August 18, 2022
Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
Aleksandar Murgaski, Máté Kiss, Helena Van Damme, et al.
Cell Reports
|
August 19, 2025
Lipid nanoparticles as a tool to dissect dendritic cell maturation pathways
Sofie Rennen, Victor Bosteels, Clint De Nolf, et al.
Science Immunology
|
May 12, 2023
LXR signaling controls homeostatic dendritic cell maturation
Victor Bosteels, Sandra Maréchal, Clint De Nolf, et al.
Cell Reports. Medicine
|
December 2, 2022
Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment
Cedric Bosteels, Karel F A Van Damme, Elisabeth De Leeuw, et al.
The Journal of Experimental Medicine
|
December 16, 2021
TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C
Levi Hoste, Lisa Roels, Leslie Naesens, et al.
The Lancet. Respiratory Medicine
|
November 10, 2021
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial
Jozefien Declercq, Karel F A Van Damme, Elisabeth De Leeuw, et al.
Science Immunology
|
January 30, 2026
Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modeling
Karel F A Van Damme, Dorine Sichien, Katrien Van der Borght, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
The EMBO Journal
|
October 30, 2025
DNGR-1 signalling limits dendritic cell activation for optimal antigen cross-presentation
Michael D Buck, Tomás Castro-Dopico, Oliver Schulz, et al.
Frontiers in Immunology
|
December 17, 2020
Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19
Karel F A Van Damme, Simon Tavernier, Nele Van Roy, et al.
Immunity
|
May 12, 2020
Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection
Cedric Bosteels, Katrijn Neyt, Manon Vanheerswynghels, et al.
Cancer Research
|
August 18, 2022
Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
Aleksandar Murgaski, Máté Kiss, Helena Van Damme, et al.
Cell Reports
|
August 19, 2025
Lipid nanoparticles as a tool to dissect dendritic cell maturation pathways
Sofie Rennen, Victor Bosteels, Clint De Nolf, et al.
Science Immunology
|
May 12, 2023
LXR signaling controls homeostatic dendritic cell maturation
Victor Bosteels, Sandra Maréchal, Clint De Nolf, et al.
Cell Reports. Medicine
|
December 2, 2022
Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment
Cedric Bosteels, Karel F A Van Damme, Elisabeth De Leeuw, et al.
The Journal of Experimental Medicine
|
December 16, 2021
TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C
Levi Hoste, Lisa Roels, Leslie Naesens, et al.
The Lancet. Respiratory Medicine
|
November 10, 2021
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial
Jozefien Declercq, Karel F A Van Damme, Elisabeth De Leeuw, et al.
Science Immunology
|
January 30, 2026
Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modeling
Karel F A Van Damme, Dorine Sichien, Katrien Van der Borght, et al.
Page
of 2